Inception Return
(10/3/1994)
|
5.79 %
|
|
YTD Return
|
12.28 %
|
|
NAVPS
(9/20/2017)
|
$24.41
|
|
Change
|
($0.06) / -0.23 %
|
|
|
Growth of $10,000
(As of August 31, 2017)
|
|
MER
|
2.52 %
|
|
Assets ($mil)
|
$87.93
|
|
Rank (1Yr)
|
18/77
|
|
Std Dev (3Yr)
|
13.82 %
|
|
Volatility Ranking (3Yr)
|
10/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
This fund’s objective is to increase the value of your investment over the long term by investing in companies in Western Europe and the UK. As part of the investment objective, this fund invests primarily in companies that are listed on recognized exchanges and that will likely benefit from merger activity and reduced trade barriers as European markets and economies restructure. It may also invest in fixed-income securities issued by governments in Western Europe and the UK.
|
Management Co.
F&C Management Limited
Managers
David Moss, Sacha El Khoury,
|
|
Asset Allocation
(As of August 31, 2017)
|
Sector Allocation
(As of August 31, 2017)
|
Geographic Allocation
(As of August 31, 2017)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Unilever NV - GDR | International Equity | Consumer Goods | European Union | 3.49% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 3.42% |
| ING Groep NV | International Equity | Financial Services | European Union | 3.36% |
| SAP SE | International Equity | Technology | European Union | 3.29% |
| Allianz SE | International Equity | Financial Services | European Union | 3.27% |
| Axa SA | International Equity | Financial Services | European Union | 3.16% |
| UBS Group AG | International Equity | Financial Services | Other European | 3.01% |
| Bayer AG | International Equity | Healthcare | European Union | 3.01% |
| ASML Holding NV | International Equity | Technology | European Union | 2.88% |
| DNB ASA | International Equity | Financial Services | Other European | 2.83% |
Performance Data
(As of August 31, 2017)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-0.35
|
-5.17
|
9.25
|
12.28
|
11.99
|
8.27
|
11.24
|
2.53
|
|
Benchmark
|
0.47
|
-5.22
|
9.00
|
11.54
|
14.64
|
7.58
|
14.46
|
3.47
|
|
Quartile Ranking
|
2
|
2
|
1
|
1
|
1
|
1
|
3
|
3
|
|
Calendar Return (%)
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
|
Fund
|
-7.99
|
22.23
|
2.56
|
18.77
|
21.77
|
1.80
|
4.59
|
13.68
|
-39.45
|
-8.87
|
|
Benchmark
|
-3.54
|
17.20
|
3.06
|
35.86
|
17.02
|
-9.65
|
-0.64
|
18.93
|
-34.99
|
-3.33
|
|
Quartile Ranking
|
3
|
2
|
1
|
4
|
1
|
1
|
2
|
2
|
4
|
3
|
MSCI ESG Fund Metrics (As of September 01, 2017)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.